| ²é¿´: 4828 | »Ø¸´: 7 | |||
wqloxy½ð³æ (ÕýʽдÊÖ)
|
[ÇóÖú]
Pipeline DrugsÊÇʲôÒâ˼£¿
|
| ÈçÌâ |
» ²ÂÄãϲ»¶
°²½ÝÂ×ÒºÏàÉ«Æ×ÖùÓë·½·¨¿ª·¢Ö¸ÄÏ
ÒѾÓÐ4È˻ظ´
2026Äêɽ¶«´óѧº£ÑóѧԺÉúÎïÓëÒ½Ò©²©Ê¿ÕÐÉú-Àîϼ¿ÎÌâ×é
ÒѾÓÐ0È˻ظ´
Ò©ÀíѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ137È˻ظ´
²©Ê¿Ñо¿ÉúÕÐÉú
ÒѾÓÐ0È˻ظ´
2026ÉêÇ뿼ºË²©Ê¿×Ô¼ö-µ°°×ÖÊ×éѧ/AI/Ò©ÎïÉè¼Æ/AIDD/»¯Ñ§ÉúÎïѧ
ÒѾÓÐ1È˻ظ´
Ò©Àíѧ¡¢ÁÙ´²Ò©Ñ§·½Ïò µ÷¼Á
ÒѾÓÐ1È˻ظ´
ÖйúÒ½Ò©ÐÐÒµ·¢Õ¹ÏÖ×´£º±ê×¼Æ·ÍÆ¶¯Ò©Æ·¼ì²âˮƽÌáÉý
ÒѾÓÐ1È˻ظ´
±ê׼ƷµÄ´¿¶È¶ÔÓÚÒ©Æ·ÖÊÁ¿µÄÓ°ÏìÓжà´ó£¿
ÒѾÓÐ0È˻ظ´
ÈçºÎÖÆ±¸·ûºÏ¼¼ÊõÒªÇóµÄÒ©Æ·±ê׼Ʒ£¿
ÒѾÓÐ0È˻ظ´
¶ÔÕÕÆ·ÔÚÒ©Æ·Ñз¢ÖеIJ»¿É»òȱÐÔ
ÒѾÓÐ0È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ÇëÎÊËÖªµÀmcg equivalent/g Õâ¸öµ¥Î»ÊÇʲôÒâ˼£¿
ÒѾÓÐ2È˻ظ´
´ó¼Ò°ïæ·ÖÎö£»Î÷°àÑÀÀϰåÕâÑùµÄ»ØÐÅÊÇʲôÒâ˼ѽ
ÒѾÓÐ19È˻ظ´
2p1/2,satÖеÄsatÊÇʲôÒâ˼£¿
ÒѾÓÐ4È˻ظ´
ÂÛÎÄͶ¸åÖÐ image "top" should be indicated. ÊÇʲôÒâ˼°¡
ÒѾÓÐ3È˻ظ´
Çë¸÷λ´ïÈ˰ïæ¿´¿´ÊÇʲôÒâ˼£¿(Íò·Ö»ð¼±£©
ÒѾÓÐ3È˻ظ´
ÓÐËÖªµÀ¾úÖêµÄÕâÖÖ±íʾÊÇʲôÒâ˼Âð£¿
ÒѾÓÐ5È˻ظ´
°ïæ¿´ÏÂÍâµ¼Õâ¾ä»°ÊÇʲôÒâ˼£¿
ÒѾÓÐ9È˻ظ´
½ÌÊÚµÄÍ·ÏÎÊÇÕâ¸ö£ºProf.dr.ir. ir.ÊÇʲôÒâ˼
ÒѾÓÐ3È˻ظ´
¡°Á¬Ðø¿Éµ¼¡±ÊÇʲôÒâ˼
ÒѾÓÐ42È˻ظ´
Ì״źó Íâµ¼»Ø¸´ÁËÕâ¾ä»°ÊÇʲôÒâ˼
ÒѾÓÐ34È˻ظ´
ÇóÉó¸åÈ˵ÄÕâ¾ä»°ÊÇʲôÒâË¼ÄØ£¿
ÒѾÓÐ4È˻ظ´
Õâ¸öÍËÐÞÒâ¼ûÊÇʲôÒâ˼£¿
ÒѾÓÐ3È˻ظ´
covered fraction ÊÇʲôÒâ˼
ÒѾÓÐ7È˻ظ´
Õâ¾ä»°ÊÇʲôÒâ˼£¿Ð»Ð»ÁË
ÒѾÓÐ3È˻ظ´
»îÐÔÌ¿£¨BPL£©ÊÇʲôÒâ˼
ÒѾÓÐ8È˻ظ´
¡¾ÌÖÂÛ¡¿ÌÕ´É»ØÐÅËÄܽâÊÍÏÂÊÇʲôÒâ˼°¡
ÒѾÓÐ3È˻ظ´
TNTsensor ÊÇʲôÒâ˼
ÒѾÓÐ3È˻ظ´
¡¾ÆäËû¡¿Çë½ÌÒ»ÏÂvacancy reference ÊÇʲôÒâ˼£¬ÔõôÌíÐ´ÄØ£¿£¿£¿
ÒѾÓÐ3È˻ظ´
withlove
ͳæ (СÓÐÃûÆø)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 263
- Ìû×Ó: 71
- ÔÚÏß: 20.5Сʱ
- ³æºÅ: 1333661
- ×¢²á: 2011-06-29
- ÐÔ±ð: MM
- רҵ: Ò©Îï·ÖÎö
2Â¥2011-12-21 15:12:56
wqloxy
½ð³æ (ÕýʽдÊÖ)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 1332.5
- É¢½ð: 13
- ºì»¨: 2
- Ìû×Ó: 783
- ÔÚÏß: 150.4Сʱ
- ³æºÅ: 120434
- ×¢²á: 2005-11-29
- רҵ: Ò©Îï·ÖÎö
3Â¥2011-12-21 15:21:56
|
±¾ÌûÄÚÈݱ»ÆÁ±Î |
» ±¾ÌûÒÑ»ñµÃµÄºì»¨£¨×îÐÂ10¶ä£©
4Â¥2011-12-21 15:46:35
ÉòСľ
½ð³æ (ÕýʽдÊÖ)
- Ó¦Öú: 5 (Ó×¶ùÔ°)
- ½ð±Ò: 1831.3
- É¢½ð: 836
- ºì»¨: 2
- Ìû×Ó: 349
- ÔÚÏß: 215.2Сʱ
- ³æºÅ: 1214426
- ×¢²á: 2011-02-26
- ÐÔ±ð: GG
- רҵ: ÓлúºÏ³É
¡ï ¡ï
zhychen2008(½ð±Ò+2): ¸Ðл»ØÌû½»Á÷ 2011-12-21 23:13:40
zhychen2008(½ð±Ò+2): ¸Ðл»ØÌû½»Á÷ 2011-12-21 23:13:40
|
A drug pipeline is the set of compounds (i.e. drugs in development) that a pharmaceutical company has under development at any given point in time. The development of drugs involves various phases that can broadly be grouped in 3 stages: pre-clinical, clinical trials and marketing (or post-approval). Pharmaceutical companies usually have a number of compounds in their pipelines. The drug pipeline is an important indicator of the value and future prospects of a company. Usually the more compounds in the pipeline, and the more advanced stage that these are in the better. Other factors that are taken into account when assessing the value of a pipeline include the size of the target market of each drug, the market share that the drug is expected to capture and the risk that it will not be approved. The cost of developing a new drug is astronomical ¨C typically a drug costs many hundreds of millions and can reach 1 billion dollars over 15¨C17 years. Assessing this risk and filtering out as early as possible compounds that may not eventually get approved is essential to the pharmaceutical industry and involves checking the effectiveness of drugs as well as the likelihood of toxic events (Adverse event prediction). |
5Â¥2011-12-21 16:39:56
wqloxy
½ð³æ (ÕýʽдÊÖ)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 1332.5
- É¢½ð: 13
- ºì»¨: 2
- Ìû×Ó: 783
- ÔÚÏß: 150.4Сʱ
- ³æºÅ: 120434
- ×¢²á: 2005-11-29
- רҵ: Ò©Îï·ÖÎö
6Â¥2011-12-21 16:54:24
wqloxy
½ð³æ (ÕýʽдÊÖ)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 1332.5
- É¢½ð: 13
- ºì»¨: 2
- Ìû×Ó: 783
- ÔÚÏß: 150.4Сʱ
- ³æºÅ: 120434
- ×¢²á: 2005-11-29
- רҵ: Ò©Îï·ÖÎö
7Â¥2011-12-21 16:54:36
likecomeon
Ìú³æ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 1.5
- Ìû×Ó: 13
- ÔÚÏß: 21.2Сʱ
- ³æºÅ: 1262250
- ×¢²á: 2011-04-11
- ÐÔ±ð: MM
- רҵ: »·¾³Î¢ÉúÎïѧ
8Â¥2011-12-22 15:43:16














»Ø¸´´ËÂ¥
wqloxy